EmR1635 Rule Text

Analysis and supporting documents used to determine effect on small business or in preparation of economic impact analysis:

This rule is implementing 2015 Act 290 and will not have an effect on small business.

Fiscal Estimate: This rule will not have a fiscal impact.

Effect on small business:

These proposed rules do not have an economic impact on small businesses, as defined in s. 227.114 (1), Stats. The Department’s Regulatory Review Coordinator may be contacted by email at [e-mail], or by calling [phone].

Agency contact person:

Sharon Henes, Administrative Rules Coordinator, Department of Safety and Professional Services, Division of Policy Development, 1400 East Washington Avenue, Room 151, P.O. Box 8366, Madison, Wisconsin 53708; telephone [phone]; email at [e-mail].

---------------------------------------------------------------------------------------------------------------------

TEXT OF RULE

Section 1. Phar 7.10 is repealed and recreated to read:

Phar 7.10 Administration of drug products and devices other than vaccines. (1) A pharmacist may administer a drug product, as defined in s. 450.01 (11), Stats., or device, as defined in s. 450.01 (6), Stats. After the pharmacist administers a prescribed drug product or device, the pharmacist or the pharmacist’s agent shall notify the prescribing practitioner or enter the information in a patient record system shared by the prescribing practitioner.

(2) A pharmacist may not administer by injection a prescribed drug product or device unless the pharmacist has successfully completed a course of study and training, approved by the Accreditation Council for Pharmacy Education, or the board, in administration techniques.

(3) A person engaged in the practice of pharmacy under s. 450.03 (1) (f) or (g) may not administer a prescribed drug product or device unless the person satisfies all of the following:

  (a) Successfully completes a course of study and training in administration technique approved by the Accreditation Council of Pharmacy Education or the board.

  (b) Administers the prescribed drug product or device only under the direct supervision of a pharmacist who has successfully completed a course of study and training in administration technique approved by the Accreditation Council of Pharmacy Education or the board.

(4) The board may approve courses of study which meet criteria substantially equivalent to criteria used by the Accreditation Council for Pharmacy Education.

Section 2. EFFECTIVE DATE. The rules adopted in this order shall take effect on publication in the Wisconsin State Journal.

(END OF TEXT OF RULE)